Research / ADI / Fundamental state Inspectable configuration
State dimensions Filing 0000006281-22-000224 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
201.84% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 93th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.capex_revenue_ratio
5.30% · OPTIONAL · VALID
Operating cash generation 80th Own-history percentile · N=15
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
40.13% · OPTIONAL · VALID
Share-count growth 73th Own-history percentile · N=11
Evidence method Yoy · gp.fundamentals.shares_outstanding
39.69% · CORE · VALID
Revenue growth 91th Own-history percentile · N=11
Evidence method Yoy · gp.fundamentals.revenue
76.81% · CORE · VALID
Inventory pressure 60th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
38.70% · OPTIONAL · VALID
Gross margin 33th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.gross_margin
65.70% · CORE · VALID
Operating margin 40th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.operating_margin
28.72% · CORE · VALID
R&D intensity 0th Own-history percentile · N=15
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
13.89% · OPTIONAL · VALID
SBC intensity 80th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
2.73% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 32 states Self-history eligible
Oct 30, 2021 9/9 normalized Level 3 Jan 29, 2022 9/10 normalized Level 3 Apr 30, 2022 9/10 normalized Level 3 Jul 30, 2022 9/10 normalized Level 3 Oct 29, 2022 9/9 normalized Level 3 Jan 28, 2023 9/10 normalized Level 3 Apr 29, 2023 9/10 normalized Level 3 Jul 29, 2023 9/10 normalized Level 3 Oct 28, 2023 9/10 normalized Level 3 Feb 3, 2024 9/10 normalized Level 3 May 4, 2024 10/10 normalized Level 3 Aug 3, 2024 10/10 normalized Level 3 Nov 2, 2024 10/10 normalized Level 3 Feb 1, 2025 10/10 normalized Level 3 May 3, 2025 10/10 normalized Level 3 Aug 2, 2025 10/10 normalized Level 3 Nov 1, 2025 10/10 normalized Level 3 Jan 31, 2026 10/10 normalized Level 3 May 2, 2026 10/10 normalized Level 3 Aug 1, 2026 10/10 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 211.20%
Current 201.84%
Delta -9.36% Capex Intensity Increased
Previous 4.00%
Current 5.30%
Delta 1.31% Cash Generation Decreased
Previous 41.11%
Current 40.13%
Delta -0.98% Dilution Decreased
Previous 40.93%
Current 39.69%
Delta -1.25% Growth Decreased
Previous 78.89%
Current 76.81%
Delta -2.08% Inventory Pressure Increased
Previous 36.18%
Current 38.70%
Delta 2.52% Margin Increased
Previous 65.43%
Current 65.70%
Delta 0.27% Profitability Decreased
Previous 30.89%
Current 28.72%
Delta -2.17% R And D Intensity Decreased
Previous 14.16%
Current 13.89%
Delta -0.28% Sbc Intensity Increased
Previous 2.39%
Current 2.73%
Delta 0.34% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.